The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...

Through transparent pricing, unlimited provider communication, and a lab-driven approach to dosage personalization, Sesame is making weight loss with compounded semaglutide more achievable for ...

Click on the status to view our full coverage. Semaglutide (Novo Nordisk) Glucagon-like peptide-1 receptor agonist To improve walking distance in patients with type 2 diabetes and symptomatic ...

There have been reports of dosing errors associated with compounded semaglutide products ... the boundaries of federal and state laws and compound these therapies only for individualized ...

"We are deeply disappointed that the (court) misapprehended or failed to take into consideration the clear and convincing evidence that demonstrates that the manufactured supply of semaglutide is ...

FDA-approved peptides like Semaglutide ... These compounds are intended for use in research settings, and purchasing them carries risks, including improper dosing and contamination.

The compound demonstrated effective pain relief in mouse models without major opioid-related side effects. Further research and clinical trials are necessary to confirm its safety and efficacy.

A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken at mid-afternoon, may be the best timing for effective asthma control as it suppresses the usual nocturnal worsening ...